Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/10
End: 08/31/11
Due: 08/31/12
Phase: N/A
Priority: Normal
Start: 05/31/09
End: 06/30/10
Due: 06/30/11
Phase: N/A
Priority: Normal
Start: 03/31/08
End: 06/30/09
Due: 06/30/10
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| An Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac Surgery | NCT01256372 | Action Pharma A/S | user2@example.com | None | 2010-10-31 | 2011-08-31 | 2012-08-31 | - | - | 2025-07-14 |
| Pharmacokinetics of AP214 Acetate in Patients Undergoing Cardiac Surgery | NCT00903604 | Action Pharma A/S | user2@example.com | None | 2009-05-31 | 2010-06-30 | 2011-06-30 | - | - | 2025-07-14 |
| Safety, Tolerability and Pharmacodynamics of AP214 Acetate in Patients Undergoing Cardiac Surgery | NCT00628264 | Action Pharma A/S | user2@example.com | None | 2008-03-31 | 2009-06-30 | 2010-06-30 | - | - | 2025-07-14 |